Search Results - "Singh, Jagdeep S.S."

Angiotensin receptor-neprilysin inhibitors: clinical potential in heart failure and beyond by Singh, Jagdeep S S, Lang, Chim C

“…Heart failure remains a major concern across the globe as life expectancies and delivery of health care continue to improve. There has been a dearth of new…”
Get full text

Dapagliflozin Versus Placebo on Left Ventricular Remodeling in Patients With Diabetes and Heart Failure: The REFORM Trial by Singh, Jagdeep S S, Mordi, Ify R, Vickneson, Keeran, Fathi, Amir, Donnan, Peter T, Mohan, Mohapradeep, Choy, Anna Maria J, Gandy, Stephen, George, Jacob, Khan, Faisel, Pearson, Ewan R, Houston, J Graeme, Struthers, Allan D, Lang, Chim C

“…To determine the effects of dapagliflozin in patients with heart failure (HF) and type 2 diabetes mellitus (T2DM) on left ventricular (LV) remodeling using…”
Get full text

A randomized controlled trial of metformin on left ventricular hypertrophy in patients with coronary artery disease without diabetes: the MET-REMODEL trial by Mohan, Mohapradeep, Al-Talabany, Shaween, McKinnie, Angela, Mordi, Ify R, Singh, Jagdeep S S, Gandy, Stephen J, Baig, Fatima, Hussain, Muhammad S, Bhalraam, U, Khan, Faisel, Choy, Anna-Maria, Matthew, Shona, Houston, John Graeme, Struthers, Allan D, George, Jacob, Lang, Chim C

“…Abstract Aim We tested the hypothesis that metformin may regress left ventricular hypertrophy (LVH) in patients who have coronary artery disease (CAD), with…”
Get full text

Sacubitril/valsartan: beyond natriuretic peptides by Singh, Jagdeep S S, Burrell, Louise M, Cherif, Myriam, Squire, Iain B, Clark, Andrew L, Lang, Chim C

“…Natriuretic peptides, especially B-type natriuretic peptide (BNP), have primarily been regarded as biomarkers in heart failure (HF). However, they are also…”
Get more information

Mean HbA1c and mortality in diabetic individuals with heart failure: a population cohort study by Elder, Douglas H.J., Singh, Jagdeep S.S., Levin, Daniel, Donnelly, Louise A., Choy, Anna-Maria, George, Jacob, Struthers, Allan D., Doney, Alex S.F., Lang, Chim C.

“…Aims Controversy exists regarding the importance of glycaemic control in patients with type 2 diabetes mellitus (T2DM) and chronic heart failure (CHF) based on…”
Get full text

Research into the Effect of Sodium-Glucose Linked Transporter 2 Inhibition on Left Ventricular Remodeling in Patients with Heart Failure and Diabetes Mellitus by SINGH, JAGDEEP S.S., MORDI, IFY, MOHAN, MOHAPRADEEP, GANDY, STEPHEN J., PEARSON, EWAN, HOUSTON, JOHN G., STRUTHERS, ALLAN D., LANG, CHIM C.

“…Introduction: DM and heart failure (HF) are lethal, with limited diabetic therapy options. Sodium-glucose linked transporter 2 (SGLT2) inhibitors have been…”
Get full text

Research into the effect Of SGLT2 inhibition on left ventricular remodelling in patients with heart failure and diabetes mellitus (REFORM) trial rationale and design by Singh, Jagdeep S S, Fathi, Amir, Vickneson, Keeran, Mordi, Ify, Mohan, Mohapradeep, Houston, J Graeme, Pearson, Ewan R, Struthers, Allan D, Lang, Chim C

“…Heart failure (HF) and diabetes (DM) are a lethal combination. The current armamentarium of anti-diabetic agents has been shown to be less efficacious and…”
Get full text

Mean HbA 1c and mortality in diabetic individuals with heart failure: a population cohort study by Elder, Douglas H.J., Singh, Jagdeep S.S., Levin, Daniel, Donnelly, Louise A., Choy, Anna‐Maria, George, Jacob, Struthers, Allan D., Doney, Alex S.F., Lang, Chim C.

“…Aims Controversy exists regarding the importance of glycaemic control in patients with type 2 diabetes mellitus ( T2DM ) and chronic heart failure ( CHF )…”
Get full text

Effect of metformin on epicardial adipose tissue in patients with coronary artery disease without diabetes: A cardiac MRI substudy of the MET-remodel trial by Al-Talabany, Shaween, Mohan, Mohapradeep, Weir-McCall, Jonathan, Gandy, Stephen, Singh, Jagdeep S.S., Mordi, Ify R., Baig, Fatima, Maria J Choy, Anna, George, Jacob, Houston, J. Graeme, Struthers, Allan.D., Khan, Faisel, Lang, Chim C.

“…Epicardial adipose tissue (EAT) is a risk factor implicated in the pathogenesis and prognosis of cardiovascular disease. Metformin has been shown to regress…”
Get full text